Related by context. All words. (Click for frequent words.) 66 ENMD # 62 NASDAQ PRCS 62 www.durect.com 61 RGB # 61 Genta Incorporated OTCBB GETA 61 Metaphore 61 Nasdaq PGNX today 61 Sym# 61 Arno Therapeutics 60 Tezampanel 60 TKB# 60 tiapamil 60 telomerase therapeutic 60 XL# anticancer compounds 60 Agenus 59 Phase Ib study 59 Zenvia ™ 59 Dynogen 59 JAK inhibitor 59 tramiprosate Alzhemed TM 59 CRLX# 59 JAK1 59 oral prodrug 59 PDE4 inhibitor 59 rxRNA 59 CORT # 59 Curon Medical 59 SWX SPPN 59 Nasdaq FURX 58 LymphoStat B TM 58 PEG SN# 58 Aplidin R 58 Alocrest 58 NLTX 58 Fero Industries Inc. 58 PRTX 58 Excaliard 58 PRAECIS PHARMACEUTICALS INCORPORATED 58 selective androgen receptor modulator 58 Elagolix 58 Transcept Pharmaceuticals 58 CEQ# 58 IL# PE#QQR 58 PHX# 58 mertansine 58 dextromethorphan quinidine 58 Glufosfamide 58 HCV protease inhibitor 58 http:/www.celgene.com 58 Phase 1b clinical trials 58 JZP 58 Archexin 58 OMNARIS Nasal Spray 58 glucokinase activator 57 CCX# 57 www.delcath.com 57 Dr. Cauwenbergh 57 Guanilib 57 generation proteasome inhibitor 57 CD# CEA 57 Ocrelizumab 57 FOLOTYN ® 57 PS# [001] 57 phase IIb clinical 57 Ascent Therapeutics 57 Ceflatonin R 57 compound INCB# 57 www.rxipharma.com 57 www.soligenix.com 57 cannabinor 57 sodium thiosulfate STS 57 Valera Pharmaceuticals 57 investigational pan BCR 57 Pimavanserin 57 DDP# 57 Mr. Armando Anido 57 AOGN 57 Gentamicin Surgical Implant 57 AeroLEF TM 57 Androxal TM 57 phase IIb trial 57 P#X# antagonist 57 mGluR2 positive 57 R#/MEM # 57 TSX VENTURE COT 57 BAJFF 57 Aegera 57 evaluating tivozanib 57 Taglich Brothers Initiates Coverage 57 Plicera 57 Nasdaq ICON Iconix 57 Azedra 57 davunetide intranasal AL 57 YONDELIS 57 OTCBB NPHC 57 SAR# [002] 56 Bicifadine 56 R roscovitine 56 liposomal formulation 56 huC# DM4 56 Ampio Pharmaceuticals Inc. 56 www.questcor.com 56 Symadex 56 Tesetaxel 56 alvespimycin 56 FISSION ENERGY CORP. Fission 56 Telatinib 56 AzaSite Xtra 56 phase IIa clinical 56 non nucleoside HCV 56 cMET 56 pradefovir 56 PSN# [002] 56 oral picoplatin 56 HGS ETR1 56 www.accentia.net 56 hypoxia activated prodrug 56 CCR9 antagonist 56 VCRT 56 Dr. Laikind 56 Ridaforolimus 56 favorable pharmacokinetic profile 56 GrowMax Agri Corp. 56 Nasdaq NPSP 56 LEVADEX TM 56 preclinical efficacy 56 Company NYSE DRH 56 Vaccinex 56 Aurexis 56 Kinetex Resources Corporation 56 www.ilgenetics.com 56 NASDAQ HYTM 56 NYSE Amex HEB 56 zanolimumab 56 torezolid phosphate 56 RXEXF 56 Epratuzumab 56 Xanafide 56 polymerase inhibitors 56 OTCBB IMNR 56 www.premdinc.com 56 Amicus Therapeutics Nasdaq FOLD 55 humanized anti 55 HGS ETR2 55 Medizone International 55 www.vivus.com 55 IMC #B 55 Carfilzomib 55 Phase Ib clinical trials 55 www.helicosbio.com 55 XmAb# 55 www.anthera.com 55 metaglidasen 55 Phase Ib II 55 Cerimon 55 tubulin inhibitor 55 MT# MEDI 55 REP# 55 XL# XL# 55 TACI Ig 55 PhytoMedical Technologies Inc. 55 GED aPC 55 Triolex 55 INCB# [003] 55 Cannabinor 55 MultiCell Technologies 55 dirucotide 55 radezolid 55 Thiarabine 55 Celmed 55 Ore Pharmaceuticals 55 Sync2 Networks Corp. 55 Personalized Immunotherapy 55 David H. Fater 55 Curacyte AG 55 investigational humanized monoclonal antibody 55 Loramyc R 55 preclinically 55 INCB# [001] 55 www.adeonapharma.com 55 romazarit 55 Cetrorelix 55 INT# [002] 55 Tombstone Exploration 55 CYGX 55 iBioPharma 55 Phase 2a clinical 55 IMA# 55 MFLU 55 ISIS # 55 Ophthotech 55 Oral NKTR 55 CYT# potent vascular disrupting 55 lixivaptan 55 NYSE Amex TAT 55 Inc. Nasdaq IDEV 55 budesonide foam 55 TSX VENTURE MBG 55 preclinical compounds 55 including eniluracil ADH 55 URG# 55 PSMA ADC 55 JAK2 inhibitor 55 octreotide implant 55 XETRA AGX today 55 Æterna Zentaris 55 Traficet EN 55 Sinobiomed 55 XmAb 55 Voreloxin 55 Indaflex TM 55 ATL/TV# 55 AKT inhibitor 55 SNGX 55 LymphoStat B belimumab 54 Aurora kinase inhibitor 54 Phase IIa trials 54 Lixivaptan 54 Eurand Pharmaceuticals 54 PRIMEZONE ViroPharma Incorporated 54 Mistral Pharma 54 ularitide 54 TBC# 54 BCR ABL inhibitors 54 Phase III confirmatory 54 Opexa 54 PREOS R 54 www.biophan.com 54 RGIN 54 novel histone deacetylase 54 ATL# [001] 54 NXL# 54 ATL# [002] 54 CDP# 54 LIMITED TSX GPR 54 Plecanatide 54 TSX TNP 54 tezampanel 54 ulimorelin 54 GSK '# 54 Dapagliflozin 54 OvaRex R 54 EnzymeRx 54 urocortin 2 54 PrevOnco 54 TRAIL receptor antibodies 54 NASDAQ IPXL today 54 Spiegelmer ® 54 BERLIN GF6 STUTTGART GF6 54 Radezolid 54 MEK inhibitor 54 Phase #/#a 54 Alexis Borisy President 54 DNAPrint Pharmaceuticals Inc. 54 TSX VENTURE GXM FRANKFURT 54 Azedra TM 54 & LSE GLPG 54 prostone 54 IGXT IntelGenx today 54 anticancer compound 54 Omacetaxine 54 CD# antibody [001] 54 Onalta 54 brivaracetam 54 Virulizin ® 54 Denarii Resources Inc. 54 www.option.com 54 www.immuneregen.com 54 BioFocus DPI Galapagos 54 Board PHPG 54 ProLindac TM 54 Nasdaq NIHD 54 TSX VENTURE UCU 54 ALD# 54 Harry Palmin President 54 OMP #M# 54 Aflibercept 54 Diatos SA 54 ONCONASE R 54 leading oral taxane 54 docetaxel Taxotere R 54 investigational monoclonal antibody 54 HQK 54 vascular disrupting agents 54 HuLuc# 54 ChromoCure Inc. 54 Clavis Pharma 54 HBRM 54 NovaScreen Biosciences 54 elotuzumab 54 Affinium Pharmaceuticals 54 Akorn Strides 54 Sunshine Biopharma 54 pharmacokinetic PK study 54 Ceftaroline 54 MEK inhibitor RDEA# 54 Changes Ticker Symbol 54 Gleevec imatinib mesylate 54 TKM PLK1 54 polymerase inhibitor 54 Phase Ib clinical 53 Tyrima 53 CB2 selective receptor agonist 53 www.integralife.com 53 Panzem R 53 LLSR 53 www.anci care.com 53 Phase IIB 53 midstage clinical 53 Daclizumab 53 Chrysalin 53 AEG# 53 KNS # 53 Iloperidone 53 immatics 53 Inc. Nasdaq AVII 53 NovaBay Aganocide compounds 53 Bortezomib 53 OTC IPXL today 53 Loramyc ™ 53 pan HDAC inhibitor 53 anticoagulant reversing agent 53 EOquin 53 Nasdaq IIVI 53 OTCQB NWMT 53 CR# vcMMAE 53 ARIKACE ™ 53 HCD# [002] 53 Dacogen injection 53 entinostat 53 PGL# 53 PXD# 53 Mipomersen 53 seliciclib CYC# 53 bardoxolone 53 Aurora kinase 53 Onco TCS 53 TSX VENTURE TKK Takara 53 TSX VENTURE URO 53 GSK# [002] 53 lumiliximab 53 Phase IIa trial 53 CALVF 53 www.BMRN.com 53 www.innovaro.com 53 AcryMed Incorporated 53 GLP toxicology studies 53 Anavex #-# 53 Exherin TM 53 RNRG 53 Factor VIIa 53 WILEX 53 HGS# 53 Atiprimod 53 MGCD# [001] 53 ZK EPO 53 TG# [003] 53 depsipeptide 53 ACAPODENE 53 Ramoplanin 53 Envirokare Tech Inc. 53 Nuvion 53 SARMs 53 PF # [002] 53 Annamycin 53 JNJ Q2 53 PEG PAL 53 TRV# [001] 53 protein kinase inhibitor 53 FormCap Corp. 53 Tolvaptan 53 TKM ApoB 53 Carl Spana Ph.D. 53 Seliciclib 53 RhuDex ® 53 Meets Primary Endpoint 53 USR Technology 53 FLXT 53 nitric oxide donating prostaglandin 53 Cavit Sciences Inc. 53 ATNAF 53 EDIG 53 Phase 2b clinical trials 53 Phase 1b trial 53 A3 adenosine receptor 53 Angiocept 53 INCB# [002] 53 PRT# 53 Phase IIa clinical 53 dose escalation Phase 53 cancer immunotherapies 53 www.viyya.com 53 www.dfg.com 53 GENIVAR Income Fund 53 Oceana Therapeutics 53 lomitapide 53 JAK3 53 BRAF inhibitor 53 nucleoside analog 53 nonclinical studies 53 www.geovax.com 53 Safinamide 53 CCX# B 53 SAR# [004] 53 SLXCF 53 OGeS 52 GammaCan 52 www.sppirx.com 52 dacetuzumab 52 IMiD 52 subsidiary Embryome Sciences 52 IRX 2 52 ProMune 52 Randomized Phase 52 drug ISA# 52 Exherin 52 Mihael Polymeropoulos MD 52 targeting CD# 52 Jiangbo Pharmaceuticals Inc. 52 elvucitabine 52 OncoVEX 52 OTCBB APCSF 52 EGS# 52 TPI ASM8 52 nalbuphine ER 52 intranasal formulation 52 Ostabolin C 52 AzaSite Plus 52 PEGylated Fab fragment 52 Montec Holdings Inc. 52 ReoStar Energy Corp. 52 ALN PCS 52 Zingo TM 52 MAXY alpha 52 www.criticalcontrol.com 52 CoreStream Energy Inc. 52 http:/www.allos.com 52 Quinamed 52 www.prosepinc.com 52 Phase IIb clinical 52 proteasome inhibitor 52 Loramyc 52 http:/www.qxmc.com 52 Loramyc TM 52 Phase IIIb clinical 52 GenWay Biotech 52 Phase IIb trials 52 Panzem R NCD 52 cancer neuroendocrine tumor 52 GLYX 52 HIV integrase inhibitor 52 Phase 2b clinical 52 Skin Cholesterol Test 52 NASDAQ LBTYK 52 Phase IIb clinical trials 52 Steven B. Ratoff 52 romidepsin 52 oral salmon calcitonin 52 Zenvia Phase III 52 ESBA# 52 confirmatory Phase III 52 CINTREDEKIN BESUDOTOX 52 DYMTF 52 Cytta Corp. 52 JAK inhibitors 52 OPKO Health Inc. 52 InB Biotechnologies 52 ITAX 52 Romidepsin 52 CoreStream Energy 52 pseudobulbar affect PBA 52 Virulizin R 52 please visit www.advaxis.com 52 NNR Therapeutics 52 Phase 2a trial 52 Retigabine 52 ADP receptor antagonist 52 radiation sensitizer 52 Ziopharm 52 POLGB 52 Proquin XR 52 NTDDS 52 Agennix AG FRANKFURT AGX 52 TASE CAMT 52 Linaclotide 52 http:/ir.cdeledu.com 52 Phase 2b trial 52 http:/www.geruigroup.com 52 CPL Biologicals 52 www.navios mlp.com 52 Genesis Bioventures 52 Synovics Pharmaceuticals 52 ALN TTR# 52 Biophage 52 oral taxane 52 www.web.com 52 MNTX 52 Retains CCG Investor Relations 52 Viprinex TM 52 IV Busulfex 52 TRIOLEX 52 ARRY 52 Frank A. Lodzinski 52 Wuxi Critical 52 AEGR 52 AGDI 52 Cethrin R 52 investigational compounds 52 Aoxing Pharmaceutical Company 52 CGLD 52 HCV protease inhibitors 52 www.atrinsic.com 52 PLK1 SNALP 52 Stock Exchange EVT 52 MEK inhibitors 52 PI3K/Akt pathway inhibitor 52 GRN# 52 Actilon 52 Inc. Nasdaq PDRT 52 Blinatumomab 52 vinorelbine tartrate 51 Evotec Neurosciences 51 OTC BB NNVC.OB 51 Mr. Bentsur 51 danoprevir 51 FRHV 51 Friedreich Ataxia FRDA 51 vidofludimus 51 Zenvia TM 51 TSX VENTURE CZO 51 midstage trials 51 iSONEP 51 Nanobody ® 51 alagebrium 51 elbion GmbH 51 Hedgehog antagonist 51 Inc. PINKSHEETS NWMT 51 tafamidis 51 TSX VENTURE PMN Pixman 51 PRX# 51 RH1 51 Pivotal Phase III 51 website www.navios.com 51 TRX1 51 DXL# 51 tesmilifene 51 Tranzyme 51 Jacob Inbar 51 AQ4N 51 Graphic Packaging Corporation 51 BCLI 51 ganetespib 51 OTCBB RDIAF announces 51 NEUGENE 51 www.helixbiopharma.com 51 TOCOSOL Paclitaxel 51 highly selective adenosine 51 MacroChem Corporation 51 Cimzia ® certolizumab pegol 51 rilonacept 51 Pafuramidine 51 epothilone 51 adipiplon 51 TSX PLI ProMetic 51 CEO Mihir Taneja 51 MCET 51 CINOD 51 Aloxi injection 51 somatostatin analogue 51 Bioniche Pharma Group 51 targeted radiotherapeutic 51 Sparrowtech Resources Inc. 51 forodesine 51 BRIM2 51 OvaRex ® MAb 51 Octreotide 51 ETEV 51 histone deacetylase HDAC inhibitor 51 oral ridaforolimus 51 GAP #B# 51 angiogenesis inhibitor 51 incyclinide 51 Trofex 51 Host Nationwide Teleconference 51 teriflunomide 51 Audited Financials 51 GALNS 51 Amrubicin 51 JAK2 inhibitors 51 Renovo Holdings 51 Bingo.com Announces 51 RELOVAIR ™ 51 vascular disrupting agent 51 Addrenex 51 Inc. PINKSHEETS RELM 51 orally bioavailable 51 BioBalance Corporation 51 Relivar 51 EVOGF 51 Dr. Stylli 51 Fresenius Biotech 51 delafloxacin 51 ONI BioPharma 51 Metiscan Inc. 51 antisense drug 51 NASDAQ GPCB today 51 EarthFirst Technologies 51 Neurodex 51 S/GSK# 51 SNWV 51 KEY.DB 51 carcinoid syndrome 51 Phase 2b 51 PINKSHEETS ZCNW 51 RNAi therapeutic targeting 51 Proxinium TM 51 IFN α 51 Nanobody 51 TDX Independence Funds 51 Abraham Drost P.Geo 51 Kissei Pharmaceutical 51 RLY# 51 www.nuinsco.ca 51 BAY #-# 51 HuMax CD4 51 Panzem 51 CIMZIA ™ 51 Integrium 51 Brownstone Resources 51 RELM Holdings 51 placebo controlled clinical 51 Fibrillex TM 51 Sandspring Resources Ltd. 51 Declares Dividend Quick Facts 51 rhMBL 51 OXi# 51 Adamis Pharmaceuticals Corporation 51 MZEI 51 BAL# [002] 51 phase IIb 51 acetonide FA 51 www.vicortech.com 51 PAOD 51 www.validsoft.com 51 Antisense 51 methylnaltrexone 50 Nasdaq UTIW 50 SUTIMCo 50 Mundoro Capital Inc. 50 bendamustine HCl 50 Iris Molecular Diagnostics 50 drug conjugate 50 BRNZ 50 hematological cancers 50 visilizumab 50 RhuDex 50 China INSOnline Corp. 50 MTVO 50 AVNA 50 CBLC# 50 Valopicitabine 50 OncoVEX GM CSF 50 class mGluR5 inhibitor 50 Acorn Factor 50 ALN RSV# 50 tanespimycin 50 volociximab 50 dutogliptin 50 DiaSys Corporation 50 ZYTO Corp Pink Sheets 50 http:/www.torreypinestherapeutics.com 50 ASX UNS 50 IPL# 50 IAP inhibitor 50 Oncolys 50 Crofelemer 50 #D#C# 50 ZYTC 50 epothilones 50 OTC Bulletin Board GPXM 50 Phase 1b 50 Ambrisentan 50 pitavastatin 50 MLN# 50 monoclonal antibody therapeutics 50 DK Sinopharma Inc. 50 SENSIO Technologies 50 Friedhelm Blobel Ph.D. 50 NUBL 50 PINKSHEETS KKUR 50 ceftazidime 50 deforolimus 50 LEP ETU 50 Aliskiren 50 Aryplase 50 NVA# 50 ibudilast 50 Synavive 50 Healthnostics MedBioWorld 50 RAPAFLO 50 Hsp# inhibitors 50 PHILand Ranch 50 eprotirome 50 http:/www.pdi-inc.com 50 Onalta ™ 50 VentiRx 50 Scivanta 50 NNVC.OB 50 PCOP 50 Icatibant 50 placebo controlled Phase 50 Adentri 50 Eltrombopag 50 atacicept 50 Phase #/#a trial 50 Vorinostat 50 EndoTAG TM -1 50 CytoFabTM 50 UPLYSO 50 HuMax EGFr 50 HCV polymerase inhibitor 50 OTCBB BFAR 50 Anticalin 50 OHR/AVR# 50 Trustcash Holdings Inc. 50 BiTE antibody 50 NGX# 50 NASDAQ BIOS 50 Saforis 50 Tracleer r 50 Enable IPC Corporation 50 SPO Medical 50 Novexel 50 rasagiline tablets 50 eniluracil 50 6R BH4 50 Pashminadepot.com 50 AP# [003] 50 triphendiol 50 LY# [002] 50 CBTE 50 IAP inhibitors 50 CA4P 50 Pazopanib 50 MXOM 50 ECTE 50 DKSP 50 NASDAQ INOD 50 sci.com 50 EHYD 50 GW# [003] 50 AutoloGel tm System 50 outlicensing 50 HIGHYAG 50 Phase Ib 50 obatoclax 50 ZYTC www.ZYTO.com 50 www.avineon.com 50 Bezielle 50 opioid induced bowel dysfunction 50 Phase 2a 50 ThermoDox R 50 AZX# 50 Orphan Therapeutics 50 MyVax R 50 Clinigene 50 CYT# 50 CuOro 50 Milnacipran 50 ruxolitinib 50 www.clenergen.com 50 Aurora Kinase 49 RNAi therapeutic 49 VioQuest Pharmaceuticals 49 preclinical 49 MoxDuo 49 H Quotient 49 Inc.announced 49 Ofatumumab 49 BioVant 49 Oglemilast 49 D Mecatronics Inc. 49 Pertuzumab 49 DR Cysteamine 49 AERx iDMS 49 Abbokinase 49 Perifosine 49 Quark Biotech 49 Swedish Orphan 49 Tasimelteon 49 mGluR5 NAM 49 Zoraxel 49 registrational 49 Igor Gonda Ph.D. 49 CIMZIA TM 49 Caleco Pharma 49 Quia Resources Inc. 49 NewHeights Software Corporation 49 Hsp# inhibition 49 BNC# 49 OXBT 49 Exelixis XL# 49 Dr. Philip Toleikis 49 JP-#/fipamezole 49 OTC MNDP 49 BrachySil TM 49 LP Nasdaq LGCY 49 Phase 2b study 49 pegylated interferons 49 bicifadine 49 Inc. PINKSHEETS TSHL 49 TRUSTCASH HOLDINGS INC. TRUSTCASH 49 BCX# 49 subcutaneous formulation 49 refractory gout 49 Vitaxin 49 Hipso Multimedia Inc. 49 Preclinical studies suggest 49 novel oral anticoagulant 49 CRx 49 Vicinium TM 49 Covalon Technologies 49 Pacific Biomarkers 49 antibody MAb 49 sJIA 49 CTT Holdings 49 talabostat 49 Genz # 49 GAMMAGARD 49 BMS # 49 Phase IIa 49 Nexavar sorafenib 49 sunitinib malate 49 GMPM 49 Amplimexon 49 HENDERSON NEVADA Marketwire #/#/# 49 MOZOBIL 49 AVE# 49 Serdaxin 49 Argatroban 49 IICN 49 AVAX 49 phase IIa 49 TNF Tumor Necrosis Factor 49 ThyroTest R 49 phase 2a 49 CAMPATH 49 Xeloda capecitabine 49 Phenoptin 49 PINKSHEETS NMKT 49 ponatinib 49 novel nucleoside analog 49 www.navstarinc.com 49 HSP# inhibitor 49 Evoltra ® 49 Actemra tocilizumab 49 PEGylated 49 teduglutide 49 Lupuzor 49 SNT MC# 49 http:/www.bphx.com 49 CoreCard Software 49 Civacir 49 Fx #A 49 MDxHealth 49 Süss MicroTec AG 49 Aultra Gold Inc. 49 Genasense ® 49 faropenem 49 www.fibertower.com 49 TSX VENTURE ZED 49 ACV1 49 oral antiviral 49 Arikace 49 Firazyr 49 BSX ALTE.BH 49 www.bphx.com 49 PINKSHEETS MCHU 49 neratinib 49 isoform selective 49 website http:/www.npsp.com 49 Tarceva TM 49 MDGC 49 Ophena TM 49 OTCBB GCHK 49 Allovectin 7 R 49 #KSB 49 Aplidin 49 multi kinase inhibitor 49 CDK inhibitor 49 Gleevec resistant 49 BZL# 49 Collagen Matrix 49 custirsen 49 Clevudine 49 TCLN 49 Aduromed 49 Kola Mining Corp. 49 SNDZ 49 Pradefovir 49 http:/www.jer.com 49 Resten NG 48 Entereg R 48 VUE Software 48 Tarsis Resources Ltd. 48 IBPM 48 Nexavar ® 48 fipamezole 48 humanized monoclonal antibody 48 NYMH 48 Inc. PINKSHEETS NBVG 48 http:/www.daystartech.com 48 injectable formulation 48 preclinical studies 48 PI3K inhibitor 48 Avanafil 48 website www.navios mlp.com 48 Scancell 48 HuMax CD# 48 Kyowa Hakko Kirin 48 Anthera 48 Tarvacin 48 Vitalstate 48 L BLP# 48 PayChest 48 TSX VENTURE VEI 48 Sudhir Agrawal D.Phil 48 XGEN Ventures Inc. 48 Teflaro 48 www.healthcareoftoday.com 48 EGCT 48 SFRX 48 un audited consolidated 48 Dasatinib 48 BMGP 48 EOquin TM 48 EP #R 48 Ventavis 48 TRC# 48 IVI Communications Inc. 48 LKAI 48 TH# [003] 48 docetaxel Taxotere ® 48 Insegia 48 Cinquil 48 MORAb 48 Promius Pharma LLC 48 NSE GEOMETRIC 48 Holdings PINKSHEETS SNMN 48 Dr. Pingpank 48 retinal vein occlusion induced 48 Mpex 48 SILU 48 Golimumab 48 reslizumab 48 receptor tyrosine kinase inhibitor 48 Quintek Technologies 48 Goldmarca Limited 48 Board CMCJ 48 renin inhibitor 48 Nitram Energy 48 relapsed leukemia 48 Cardio Vascu Grow 48 Rescula 48 CAGM 48 AVN# [001] 48 ALDA announces 48 GDIR 48 silodosin 48 Rebif ® 48 PPJE 48 Aesthera Corporation 48 SoftM AG 48 www.alliedhealthcare.com 48 tasocitinib 48 axitinib 48 Alvesco R 48 ocrelizumab 48 China Baicaotang 48 PROMACTA 48 ComGenex 48 Fodosine 48 NovaMed Pharmaceuticals 48 Jaiva Technologies 48 DCCR 48 PINKSHEETS NWMT PowerRating 48 SunSi Energies Hong Kong 48 TeamStaff GS 48 Tofacitinib 48 DCVax R 48 Ecologic Transportation 48 oxypurinol 48 Limited NYSE KZL 48 NBVG 48 IntePharm 48 VAPRISOL 48 CGEN # 48 Raptiva ® 48 hematological indications